Showing posts with label Biomira. Show all posts
Showing posts with label Biomira. Show all posts
Sep 7, 2007
Biomira Inc., Stimuvax(R) Phase II data highlight, non-small cell lung cancer
Sept. 5, 2007- Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) : presentation of three-year survival results from a randomized Phase II trial of the Stimuvax(R) MUC-1 vaccine in non-small cell lung cancer (NSCLC)... Biomira's Press Release -
Subscribe to:
Comments (Atom)
